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ABSTRACT 
Human methylmalonyl-CoA mutase (hMCM) is an adenosylcobalamin-dependent 
enzyme that catalyses the structural rearrangement of (R)-methylmalonyl-CoA to 
succinyl-CoA as part of the catabolism of the branched chain amino acids valine, 
leucine and isoleucine, odd chain fatty acids and intermediates of cholesterol 
metabolism. Reactions that require adenosylcobalamin (AdoCbl) have been 
intensively studied, and the first step in the catalysis is widely agreed to involve 
homolytic cleavage of the unusual carbon-cobalt bond in the cofactor. A reliable 
source of recombinant hMCM would be useful in defining more fully the 
mechanistic pathway of AdoCbl-dependent enzymes. 
Recombinant hMCM overexpressed in E. coli forms insoluble aggregates of 
inactive protein known as inclusion bodies. hMCM inclusion bodies were purified, 
solubilised and then several different in vitro refolding techniques were tested in 
attempts to produce active recombinant hMCM from purified solubilised inclusion 
body material. These methods included refolding by rapid dilution, refolding by 
dialysis, detergent-assisted refolding, refolding by gel filtration chromatography 
and chaperonin-assisted refolding. Chaperonin-assisted refolding necessitated the 
strain DHl/pGroESL. 
Refolding by rapid dilution of the GdmHCl-solubilised inclusion bodies into a 
refolding buffer was judged to be the simplest and most effective method, however 
the refolding process was extremely inefficient. Refolding by rapid dilution was 
scaled up to 2 litres to produce as much active hMCM as possible. The refolded 
protein was concentrated by batch adsorption to and stepwise elution from 
hydroxyapatite, and further purified using a synthesised 5' adenosylcobalamin-
agarose 'affinity' chromatography column. The final refolded hMCM preparation 
contained a single ~ 29 kDa contaminant protein, tentatively identified as E. coli 
branched-chain amino acid aminotransferase (EC 2.6.1.42), present in 
approximately equal amounts to the hMCM, and had a specific activity of ~ 3.11 
units/mg. 
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